SCHEMBL29619646

SCHEMBL29619646

CS(=O)(=O)O[C@@H]1CCN(C(=O)O)[C@@H](C(=O)O)C1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
AGTR2 P50052 7/20 0.36
MMP2 P08253 1/20 0.32
ANPEP P15144 1/20 0.32
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25368595 1.00 ATM (0.37) ATMAGTR2MMP2ANPEPRAB9A
SCHEMBL1251163 0.84 ATM (0.42) ATMAGTR2MMP2ANPEP
SCHEMBL21682443 0.84 ATM (0.42) ATMAGTR2MMP2ANPEP
SCHEMBL1251161 0.84 ATM (0.42) ATMAGTR2MMP2ANPEP
SCHEMBL1251167 0.84 ATM (0.42) ATMAGTR2MMP2ANPEP
SCHEMBL6917231 0.84 ATM (0.42) ATMAGTR2MMP2ANPEP
SCHEMBL20566560 0.83 ALDH1A1 (0.30)
SCHEMBL20570544 0.83 ALDH1A1 (0.30)
SCHEMBL16717011 0.83 ALDH1A1 (0.30)
SCHEMBL16717012 0.83 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4054591-A1 COMBINATION THERAPY FOR TREATING CANCER Astrazeneca AB (SE) 2022-09-14 EP disclosed
CN-114599372-A Combination therapy for the treatment of cancer 阿斯利康(瑞典)有限公司 2022-06-07 CN disclosed